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Abstract
Introduction:  A number of studies has addressed the possible association between patent
foramen ovale (PFO) and stroke. However, the role of PFO in the pathogenesis of cerebral
ischemia has remained controversial and most studies did not analyze patient subgroups stratified
for gender, age and origin of stroke.
Methods: To address the role of PFO for the occurrence of cerebral ischemia, we investigated
the prevalence of right-to-left shunt in a large group of patients with acute stroke or TIA. 763
consecutive patients admitted to our hospital with cerebral ischemia were analyzed. All patients
were screened for the presence of PFO by contrast-enhanced transcranial Doppler sonography at
rest and during Valsalva maneuver. Subgroup analyses were performed in patients stratified for
gender, age and origin of stroke.
Results: A right-to-left shunt was detected in 140 (28%) male and in 114 (42%) female patients
during Valsalva maneuver, and in 66 (13%) and 44 (16%) at rest respectively. Patients with right-to-
left shunt were younger than those without (P < 0.001). PFO was associated with stroke of
unknown origin in male (P = 0.001) but not female patients (P > 0.05). After adjusting for age no
significant association between PFO and stroke of unknown origin was found in either group.
Conclusion: Our findings argue against paradoxical embolization as a major cause of cerebral
ischemia in patients with right-to-left shunt. Our data demonstrate substantial gender-and age-
related differences that should be taken into account in future studies.
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Introduction
Despite numerous studies published in the past two dec-
ades, the role of patent foramen ovale (PFO) as a risk fac-
tor of stroke remains a matter of debate. A significant
correlation between PFO and cryptogenic stroke has
repeatedly been shown. However, most studies included
only small numbers of patients and thus did not allow to
adjust the analysis for gender and age.
The aim of our study was to re-evaluate the association
between right-to-left shunts (RLS) and stroke subtypes in
a patient community large enough to allow multivariate
analysis with special consideration of gender-related dif-
ferences.
Methods
Subjects
The records of 973 consecutive patients examined
between January 1997 and December 2005 at the Neurov-
ascular Laboratory of the Department of Neurology at the
Klinikum Rechts der Isar, Technische Universitaet
Muenchen, were retrospectively reviewed. 210 patients
without definite diagnosis of cerebral ischemia and those
with artificial heart valves were excluded.
Complete clinical neurological examination, electrocardi-
ogram, and sonographic examination of the extra- and
intracranial arteries were carried out in all patients, as well
as a cerebral CT or MRI examination, or both. Echocardi-
ography was performed in 683 patients (89.5%). A 4-lead
24-hour ECG was performed routinely.
All baseline ischemic events were classified according to
the TOAST criteria using all diagnostic data available, [1]
with one modification: Strokes with conflicting mecha-
nisms were subsumed under "other etiology" instead of
classifying them as cryptogenic. Therefore the latter sub-
group truly represented strokes without any identifiable
etiology.
The TOAST subtyping was performed by one physician
(H.P.) who was blinded for the results of the TCD testing.
c-TCD Methodology
For microembolic monitoring, a 2-MHz pulsed-wave
transcranial Doppler device (MULTI-DOP, DWL Elektro-
nische Systeme, Sipplingen, Germany) was used for
simultaneous insonation of both middle cerebral arteries
(MCA) using simultaneous 64-point FFT and bigate tech-
nique. An intensity threshold of = 11 dB and a time win-
dow of 20 seconds after the start of the injection of
galactose (Echovist®) were chosen.
The patient was placed supine. The transducer was fixed in
position with the use of a standard headset. The embolic
signals were recorded after bolus injection of galactose
(Echovist®) via the right antecubital vein followed by a
flush injection of 5 mL of normal saline. Five seconds after
start of the injection, patients had to perform a Valsalva
maneuver. This was monitored by means of a pressure
gauge, which was connected to a flexible tube with a snor-
kel mouthpiece. The patients were asked to maintain a
pressure of 4000 Pa (40 mbar) for 5 seconds. Simultane-
ous monitoring of the Doppler spectrum allowed us to
demonstrate an increased intrathoracic pressure as shown
by a reduction in the mean velocity in the MCA of at least
25%. In case of a positive finding, the examination was
repeated at rest to discriminate functional large versus
small shunts.
C-TCD was performed in every case according to our pre-
viously published protocol.[2] Except for the choice of
contrast medium, our protocol conforms to the Consen-
sus conference of Venice.[3] To ensure a maximum degree
of standardization, we used commercially available galac-
tose instead of agitated saline.
Statistical Analysis
Continuous data are shown as mean and standard devia-
tion (SD); categorical variables are expressed as absolute
and relative frequencies. Differences were tested by chi-
square and Mann-Whitney U-test as adequate. Associa-
tions between PFO, confounding factors, and different
subtypes of stroke were calculated by logistic regression
analysis and described using odds ratios (OR) with 95%
confidence intervals (CI). The analyses were carried out
on the dataset stratified by gender.
All calculations were performed using SPSS 13.0 software
(SPSS Inc., Chicago, IL, USA).
Results
Study Population
Basic characteristics are given in Table 1.
Detection of embolic signals (ES)
RLS was detected in 140 (28%) male and in 114 (42%)
female patients during Valsalva maneuver (P < 0.001). 66
(13%) male and 44 (16%) female patients showed RLS at
rest. Both male and female ES-positive patients were
younger (P < 0.001) and had fewer traditional vascular
risk factors than participants of the same gender without
RLS (P < 0.01).
In male patients presence of RLS was significantly associ-
ated with stroke of unknown origin, whereas in female
patients the association did not reach significance (Table
2). No stronger association was found in either men or
women for the different stroke subtypes and ES at rest
(Table 3).Journal of Negative Results in BioMedicine 2008, 7:7 http://www.jnrbm.com/content/7/1/7
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Female ES positive patients showed a lower prevalence of
atrial fibrillation (P < 0.001). In male ES positive patients
no significant association with atrial fibrillation was
found.
The crude odds ratios confirmed that male stroke patients
with RLS are at higher risk for cryptogenic strokes (OR
2.08; 95% CI 1.37–3.14). Multiple logistic regression
analysis with adjustment for age leads to a substantial
decrease of the effect of the PFO (aOR 1.56; 95% CI 1.00–
2.43), which is no longer significant. The corresponding
values for female patients showed a nonsignificant risk for
cryptogenic stroke for ES-positive patients (OR 1.60; 95%
CI 0.98–2.64), an effect which completely disappeared
after adjustment for age (aOR 0.97; 95% CI 0.78–2.22).
Stroke of unknown origin in men and women was associ-
ated with younger age (P < 0.001).
Discussion
We found a significant association between RLS and cryp-
togenic stroke. This has frequently been reported in previ-
ous publications, which initially led to the consideration
of PFO as an important risk factor in stroke. [4-9] Also in
accordance with previous studies, ES positive patients
were younger and, as expected, less likely to have tradi-
tional risk factors. A higher prevalence of PFO in young
subjects has also been reported in the general popula-
tion.[10,11] The association of RLS and cryptogenic
stroke might therefore be coincidence. When adjusting for
age, there was no longer a significant correlation between
RLS and cryptogenic stroke in our study, which reduced
the suggested statistical association between cryptogenic
stroke and PFO. This is in line with a recently published
population-based study which also describes a much
weaker association between PFO and cryptogenic stroke
than has been reported earlier.[12,13]
Table 1: Basic characteristics of the study population
Overall Study Population (n = 763) Male Patients (n = 494) Female Patients (n = 269)
Age, y, mean (SD) 58.2 (14.7) 59.8 (13.7) 55.2 (16.0)
Hypertension, n (%) 462 (61) 323 (65) 139 (52)
Diabetes mellitus, n (%) 126 (17) 99 (20) 27 (10)
Smoker (current/former), n (%) 365 (48) 265 (54) 100 (37)
Hyperlipidemia, n (%) 321 (42) 222 (45) 99 (37)
Stroke subtypes
Atherothrombotic, n (%) 109 (14) 80 (16) 29 (11)
Cardioembolic, n (%) 160 (21) 109 (22) 51 (19)
Lacunar, n (%) 191 (25) 133 (27) 58 (22)
Other, n (%) 55 (7) 27 (5) 28 (10)
Unknown, n (%) 248 (33) 145 (29) 103 (38)
Symptoms = 24 hours, n (%) 276 (36) 164 (33) 112 (42)
Previous stroke or transient ischemic attack, n (%) 136 (18) 89 (18) 47 (18)
Atrial fibrillation, n (%) 94 (12) 67 (14) 27 (10)
History of myocardial infarction, n (%) 62 (8) 52 (11) 10 (4)
Migraine, n(%) 36 (5) 7 (1) 29 (11)
Table 2: Relative frequency of ES in different stroke subtypes
Stroke Subtypes ES-Positive during Valsalva, n (%) ES-Negative, n (%) Difference P-value
Male patients (n = 494)
Atherothrombotic 16 (20.0) 64 (80.0) 0.078
Cardioembolic 28 (25.7) 81 (74.3) 0.548
Lacunar 32 (24.1) 101 (75.9) 0.217
Other 7 (25.9) 20 (74.1) 1.000
Unknown 57 (39.3) 88 (60.7) 0.001
Female patients (n = 269)
Atherothrombotic 15 (51.7) 14 (48.3) 0.322
Cardioembolic 19 (37.3) 32 (62.7) 0.436
Lacunar 21 (36.2) 37 (63.8) 0.298
Other 8 (28.6) 20 (71.4) 0.157
Unknown 51 (49.5) 52 (50.5) 0.076Journal of Negative Results in BioMedicine 2008, 7:7 http://www.jnrbm.com/content/7/1/7
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Unlike most previous studies, we stratified for gender: In
female patients, who were significantly more likely to
show RLS, the correlation between RLS and cryptogenic
stroke did not reach significance and further decreased
after adjusting for age. However, among male patients
cryptogenic stroke still weakly correlated with RLS in mul-
tivariate analysis (CI 1.00–2.43). Conflicting with our
results, neither the autoptic study of Hagen et al. nor the
abovementioned population-based study showed the
incidence of PFO to differ significantly between men and
women.[11,12,14] Of both previous large multicenter
studies only the PFO/ASA collaborative study reported a
significant correlation of female gender and PFO.[4,15]
The reasons for any gender-related differences among
stroke patients remain uncertain and require further
exploration.
Our results furthermore question the common theory of
paradoxical embolism: Presuming arterial embolism via
PFO secondary to a venous embolic source, the amount of
shunt volume would be expected to correlate with the risk
of stroke. This thesis has support from prior TEE-based
studies.[16,17] Anzola et al found that detection of more
than 10 bubbles by c-TCD correlated with stroke recur-
rence.[18] However, the number of patients included in
these studies were small, and the criteria for grading the
size and thresholds for distinguishing a large shunt from
a small one were arbitrary. In contrast, in both previous
large TEE-based multicenter studies, PFO size failed as a
significant predictor of stroke recurrence.[4,15] Further
studies revealed that the amount of contrast shunting did
not correlate with the size of the PFO whether measured
by two-dimensional TEE or invasively by balloon siz-
ing.[19] Exploiting the method of c-TCD, we detected the
shunted contrast medium directly in the target organ. Fur-
thermore our method allowed us to discriminate between
the presence of a shunt at rest versus RLS during Valsalva
maneuver. Only in the first subgroup would the condition
for paradoxical embolism be continuously satisfied. In
the remaining patients, particular circumstances would be
required that cause a transient right-to-left intracardiac
shunt precisely at the moment an embolus passes the
right atrium. This is less likely, and previous investigations
did not reveal an association between Valsalva-provoking
activities preceding stroke onset and the presence of
PFO.[5,20,21] Hence, we expected a particularly high per-
centage of patients with RLS at rest among patients who
otherwise had no identifiable causes of stroke. However,
this was not the case;
Another possible explanation for stroke secondary to PFO
but independent of paradoxical embolism is secondary
cardiac arrhythmias.[22] We did not find atrial fibrillation
to be associated with RLS. Thus, our study does not pro-
vide support for cardiac arrhythmia as a relevant mecha-
nism of stroke in PFO carriers. These findings are in line
with previous studies.[20]
Other possible explanations include abnormalities of the
endocardial surface of the septum or within the PFO that
are a focus for thrombus formation.[23] A substantial lim-
itation is that c-TCD is not applicable in detecting distinc-
tive features like an atrial aneurysm. A further
unavoidable limitation of this method is that patients
with severe stroke and very old patients are probably
underrepresented, as the former may not be able to per-
form Valsalva maneuver and in the latter group it might
be difficult to perform the transcranial Doppler examina-
tion because of insufficient "bone windows."
Despite these limitations, the large number of patients
included and the use of c-TCD contribute new arguments,
particularly by weakening the thesis of a significant corre-
lation between PFO and cryptogenic stroke and assessing
potential gender-related differences that should be taken
into account in future studies.
Table 3: ES at rest in the patients who were ES-positive during Valsalva
Stroke Subtypes ES-Positive at Rest, n (%) ES-Negative at Rest, n (%) Difference P-value
Male patients (n = 140)
Atherothrombotic 8 (50.0) 8 (50.0) 1.000
Cardioembolic 16 (57.1) 12 (42.9) 0.291
Lacunar 13 (40.6) 19 (59.4) 0.427
Other 2 (57.1) 5 (42.9) 0.447
Unknown 27 (47.4) 30 (52.6) 1.000
Female patients (n = 114)
Atherothrombotic 6 (40.0) 9 (60.0) 1.000
Cardioembolic 10 (52.6) 9 (47.4) 0.201
Lacunar 8 (38.1) 13 (61.9) 1.000
Other 4 (50.0) 4 (50.0) 0.709
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